Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Cancers”

8,484 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 8,484 results

Early research (Phase 1)WithdrawnNCT04500548
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study

Who this might be right for
Constitutional Mismatch Repair Deficiency SyndromeHematopoietic and Lymphoid Cell NeoplasmLynch Syndrome+9 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06052826
What this trial is testing

Geriatric Assessment Guided Interventions to Accelerate Functional Recovery After CAR-T Therapy for Patients 60 Years and Older With B-cell Non-Hodgkin Lymphoma or Multiple Myeloma, GOCART Study

Who this might be right for
B-Cell Non-Hodgkin LymphomaMultiple Myeloma
City of Hope Medical Center 164
Not applicableNot Yet RecruitingNCT07525024
What this trial is testing

KSD-101 in Patients With EBV-associated Hematological Malignancies

Who this might be right for
EBV Associated Lymphoid Neoplasms
Ruijin Hospital 80
Testing effectiveness (Phase 2)Ended earlyNCT01453088
What this trial is testing

Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older

Who this might be right for
Multiple Myeloma
Hackensack Meridian Health 63
Not applicableLooking for participantsNCT07352761
What this trial is testing

Bilateral Uterine Artery Occlusion During Laparoscopic Myomectomy

Who this might be right for
Uterine Fibroids (Leiomyoma)MyomectomyMyomectomy; Surgical Blood Loss
Alexandria University 60
Not applicableNot Yet RecruitingNCT05752890
What this trial is testing

A Novel Biomarker for Response and Prognosis of HBV-related Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatitis b VirusRadiotherapy+1 more
National Taiwan University Hospital 95
Large-scale testing (Phase 3)Looking for participantsNCT05243797
What this trial is testing

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

Who this might be right for
Multiple Myeloma
European Myeloma Network B.V. 1,594
Testing effectiveness (Phase 2)Study completedNCT00091260
What this trial is testing

CC-5013 With or Without Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

Who this might be right for
Multiple Myeloma
Vaishali Sanchorawala 82
Early research (Phase 1)Enrolling By InvitationNCT06827782
What this trial is testing

Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma

Who this might be right for
Refractory/Recurrent Central Nervous System Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University 42
Testing effectiveness (Phase 2)Ended earlyNCT00275262
What this trial is testing

Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation

Who this might be right for
Hodgkin DiseaseLymphoma, Non-HodgkinMultiple Myeloma+1 more
Abbott 25
Not applicableStudy completedNCT06369662
What this trial is testing

CD155 Expression in Acute Myeloid Leukemia

Who this might be right for
NeoplasmsHematologic NeoplasmsLeukemia+2 more
Assiut University 93
Not applicableLooking for participantsNCT05641961
What this trial is testing

Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care

Who this might be right for
Childhood CancerHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
University of California, San Francisco 30
Large-scale testing (Phase 3)Study completedNCT02312258
What this trial is testing

Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT)

Who this might be right for
Multiple Myeloma
Takeda 706
Not applicableLooking for participantsNCT05921318
What this trial is testing

Beijing Protocol in Patients Receiving More Than 5/10 HLA-mismatched Allo-HSCT

Who this might be right for
Hematologic MalignancyStem Cell Transplant Complications
Peking University People's Hospital 20
Testing effectiveness (Phase 2)Study completedNCT01802879
What this trial is testing

Study to Allow Access to Single Agent Panobinostat for Patients Who Are on s.a. Panobinostat Treatment in a Novartis-sponsored Study and Continue to Benefit From the Treatment as Judged by the Investigator

Who this might be right for
Hematologic Neoplasms
Novartis Pharmaceuticals 9
Not applicableUnknownNCT06258096
What this trial is testing

LI-TASTE Study: Light for Taste

Who this might be right for
Multiple Myeloma
Academic Centre for Dentistry in Amsterdam 52
Not applicableLooking for participantsNCT07260370
What this trial is testing

The Difference of microRNA and Circulating Tumor Cells in Blood Among Cancer Patients With Immunotherapy

Who this might be right for
microRNACirculating Tumor CellsImmunotherapy
Chang Gung Memorial Hospital 300
Testing effectiveness (Phase 2)Ended earlyNCT01745913
What this trial is testing

Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic SyndromeAcute Lymphocytic Leukemia+2 more
Weill Medical College of Cornell University 2
Early research (Phase 1)WithdrawnNCT02658396
What this trial is testing

GO-203-2C + Bortezomib For Relapsed Or Refractory MM

Who this might be right for
Multiple MyelomaMultiple Myeloma in RelapseRefractory Multiple Myeloma
Dana-Farber Cancer Institute
Not applicableActive Not RecruitingNCT00039676
What this trial is testing

Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer

Who this might be right for
Waldenstrom MacroglobulinemiaChronic Lymphocytic LeukemiaHodgkin Disease+2 more
National Cancer Institute (NCI) 1,836
Load More Results